Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 1.25% is 28% above its 1-year average of 0.98%, around the middle of its 1-year range (0.00%–3.13%).
As of the fiscal period ended Friday, July 31, 2026. 7.91% above its 12-month average of 1.16%.
Reported quarterly debt to assets ratio; no daily interpolation. Q1 FY2026 (2026-07-31): 1.25%.
DEBT TO ASSETS RATIO
1.25%
DEBT TO ASSETS RATIO AVG TTM
1.16%
DEBT TO ASSETS RATIO AVG 3Y
N/A
DEBT TO ASSETS RATIO AVG 5Y
N/A
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+7.91%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 847 covered companies
CURRENT VS SECTOR MEDIAN
+1289.48%
vs the sector median at left
MiniMed Group, Inc. Common Stock
Market Cap
$5.49B
Debt to Assets Ratio
1.25%
TTM Avg
1.16%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.31B
Debt to Assets Ratio
0.21%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.25B
Debt to Assets Ratio
0.69%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.25B
Debt to Assets Ratio
0.30%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.75B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiniMed Group, Inc. Common Stock (MMED) | $5.49B | 1.25% | 1.16% | N/A | N/A |
| RadNet, Inc. (RDNT)vs › | $5.51B | 0.52% | N/A | N/A | N/A |
| CG Oncology Inc. (CGON)vs › | $5.61B | 0.01% | N/A | N/A | N/A |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.31B | 0.21% | N/A | N/A | N/A |
| Doximity, Inc. (DOCS)vs › | $5.28B | 0.01% | N/A | N/A | N/A |
| Sotera Health Company (SHC)vs › | $5.25B | 0.69% | N/A | N/A | N/A |
| CRISPR Therapeutics AG (CRSP)vs › | $5.25B | 0.30% | N/A | N/A | N/A |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.75B | 0.01% | N/A | N/A | N/A |
| Kodiak Sciences Inc. (KOD)vs › | $5.79B | 0.37% | N/A | N/A | N/A |
| Cogent Biosciences, Inc. (COGT)vs › | $5.17B | 0.29% | N/A | N/A | N/A |
Debt/Assets
1.3%
Debt/Equity
0.02
Current Ratio
1.81
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-07-31 | 1.25% |
| 2026-04-24 | 3.13% |
| 2026-01-31 | 0.25% |
| 2025-10-31 | 0.00% |
| 2025-04-30 | 0.26% |
